9788419284501.Egan_Manual de urgencias oftalmológicas

388 Sección 8 Neurooftalmología

3. Mojon DS, Hedges TR 3rd, Ehrenberg B, et al. Association between sleep apnea syndrome and nonarte ritic anterior ischemic optic neuropathy. Arch Ophthalmol . 2002;120(5):601-605. 4.Purvin V, Sundaram S, Kawasaki A. Neuroretinitis: review of the literature and new observations. J Neuro-Ophthalmol . 2011;31:58-68. 5. Henderson AD, Tian J, Carey AR. Neuro-ophthalmic manifestations of sarcoidosis. J Neuroophthalmol . 2020. doi:10.1097/WNO.0000000000001108. Published online ahead of print, Oct 26, 2020. 6. Hayreh SS, Zimmerman MB. Nonarteritic anterior ischemic optic neuropathy: natural history of visual outcome. Ophthalmology . 2008;115(2):298-305.e292. 7. Newman NJ, Scherer R, Langenberg P, et al. The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study. Am J Ophthalmol . 2002;134(3):317-328. 8. Chan CC, Paine M, O’Day J. Steroid management in giant cell arteritis. Br J Ophthalmol . 2001;85(9):1061-1064. 9. Villiger PM, Adler S, Kuchen S, et al. Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomized, double-blind, placebo-controlled trial. Lancet . 2016;387(10031):1921-1927. 10. Newman NJ. The optic neuritis treatment trial (Commentary). Ophthalmology . 2020;127(4):S172-S173. 11. Trobe JD, Sieving PC, Guire EK, Fendrick AM. The impact of the optic neuritis treatment trial on the practices of ophthalmologists and neurologists. Ophthalmology . 1999;106(11):2047-2053. 12. Boomer JA, Siatkowski RM. Optic Neuropathy in adults and children. Semin Ophthalmol . 2003;18(4):174-180. 13. Chang MY, Pineles SL. Pediatric optic neuritis. Semin Pediatr Neurol . 2017;24(2):122-128. 14.Bonhomme GR, Mitchell EB. Treatment of pediatric optic neuritis. Curr Treat Options Neurol . 2012;14(1):93-102. 15. Morrow SA, Fraser JA, Day C, et al. Effect of treating acute optic neuritis with bioequivalent oral vs intra venous corticosteroids. JAMA Neurol . 2018;75(6):690-696.

Copyright © 2023 Wolters Kluwer, Inc. Unauthorized reproduction of the content is prohibited.